Investor

The company, which uses AI to help companies manage value-based care contracts, will use the funds to grow its team and scale its platform.

The funding comes a year after the company secured $70 million in a Series B funding round.

The Australian company offers its members access to AI agents that analyze their health data, lifelong health plans, whole-body testing and a personal doctor.

The funds will be used to grow the company's engineering and commercial workforce, enhance product development, and accelerate integration with payers and providers.

Plexāā, maker of the Bloom medical device for breast surgery, scores $4.5 million in funding.

The company offers mental healthcare for children and their families and will use the funds to expand its reach.

Connor Glass, founder and CEO of Phantom Neuro, discusses the company's muscle-machine interface that allows individuals with limb loss to control robotic limbs and systems using electrical activity from their own muscles.

The company will use the funds to advance its AI-enabled robotic platform for cataract and other eye surgeries, with plans to begin human clinical trials this year.

The Series E funding comes four months after the company secured $250 million in a Series D round.